GlassScriptPhysician profile
Sarah Murfey
NPI 1558663344
$8,433.82
in general payments reported to CMS, 2019-2025
48 companies · $578 in 2025
The $578 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,304 · 2022: $2,218 · 2023: $1,869 · 2024: $1,465 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,847 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,846.96 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $696.68 | 2021-2025 | Xtandi, Padcev |
| Dendreon Pharmaceuticals LLC | $693.08 | 2021-2024 | Provenge |
| Pfizer INC. | $499.10 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $464.68 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $447.21 | 2021-2025 | Erleada |
| Coloplast Corp | $436.26 | 2021-2024 | Speedicath |
| Olympus America INC. | $388.12 | 2022-2025 | Itind System |
| Myovant Sciences INC. | $378.16 | 2021-2022 | |
| Antares Pharma, INC. | $329.06 | 2021-2025 | Tlando, Xyosted |
| Blue Earth Diagnostics | $288.52 | 2021-2024 | |
| Teleflex LLC | $278.14 | 2021-2024 | Urolift |
| Astrazeneca Pharmaceuticals LP | $262.60 | 2021-2025 | Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $252.29 | 2021-2025 | |
| Urovant Sciences INC | $247.05 | 2021-2022 | |
| Abbvie INC. | $244.30 | 2022-2025 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $236.24 | 2021-2022 | |
| Tolmar, INC. | $214.27 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $193.82 | 2021-2024 | Keytruda, Welireg, Lynparza |
| Rochester Medical Corporation | $162.09 | 2021-2022 | |
| Abc Home Medical Supply, INC. | $156.55 | 2022-2025 | |
| Accord Healthcare, INC. | $145.24 | 2022-2025 | |
| Convatec INC. | $144.26 | 2021-2024 | |
| 180 Medical, INC. | $131.06 | 2022-2024 | Gentlecath Glide, Rusch |
| Hollister Incorporated | $117.08 | 2021-2023 | Onli, Infyna Chic, Vapro |
| Clarus Therapeutics INC. | $116.35 | 2021 | |
| Boston Scientific Corporation | $110.84 | 2021-2024 | Rezum Generator |
| Endo Pharmaceuticals INC. | $84.77 | 2021-2024 | Xiaflex, Aveed |
| Dentsply Ih INC. | $83.71 | 2021-2023 | Lofric |
| Axonics, INC. | $79.95 | 2022-2023 | Bulkamid, Axonics |
| Mission Pharmacal Company | $50.26 | 2021-2023 | Uribel |
| Angiodynamics, INC. | $45.35 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $44.17 | 2021-2022 | |
| Urogen Pharma, INC. | $40.64 | 2024-2025 | |
| Allergan, INC. | $35.47 | 2021 | |
| Verity Pharmaceuticals INC. | $35.19 | 2025 | Trelstar |
| Smith+Nephew, INC. | $33.23 | 2024 | Stravix Pl, Grafix |
| Novartis Pharmaceuticals Corporation | $31.30 | 2024 | |
| Ambu INC. | $29.86 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $24.94 | 2023 | Bard Urinary Drainage Bag |
| Laborie Medical Technologies Corp. | $23.45 | 2024 | Goby |
| Procept Biorobotics Corporation | $23.17 | 2025 | |
| Azurity Pharmaceuticals, INC. | $23.03 | 2025 | Azmiro |
| Travere Therapeutics, INC. | $21.98 | 2022 | |
| Progenics Pharmaceuticals, INC. | $21.68 | 2024 | |
| Abbott Laboratories | $20.32 | 2021 | |
| Endo USA, INC. | $17.44 | 2024 | Xiaflex |
| Foundation Medicine, INC. | $16.02 | 2021 | |
| Medtronic, INC. | $14.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Murfey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.